Skip to main content

Coughlin Timothy

In the past year, 3 open-market sale filings worth $1.27M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$1.27M
3 filings
Net
−$1.27M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Coughlin Timothy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TVTX Travere Therapeutics, Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 16, 2026 (view filing)Jun 124 daysCoughlin TimothyDirectorSSale−10.0K$50.07−$500.7K−15.1%56.3K after10b5-1
May 19, 2026 (view filing)May 154 daysCoughlin TimothyDirectorSSale−3.25K$43.49−$141.3K−5.9%52.3K after10b5-1
Nov 4, 2025 (view filing)Oct 314 daysCoughlin TimothyDirectorSSale−18.0K$35.03−$630.5K−24.5%55.5K after10b5-1

ATYR aTYR PHARMA INC

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 3, 2024 (view filing)May 304 daysCoughlin TimothyDirectorPPurchase+50.0K$1.75+$87.5K+833.3%56.0K after

FATE Fate Therapeutics Inc

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 6, 2022 (view filing)Jun 33 daysCoughlin TimothyDirectorSSale−1.44K$22.81−$32.8K−2.4%57.6K after